Dural Adhesive Agent for the Surgical Market Size was valued at USD 178.5 Mn in 2023 and is predicted to reach USD 263.2 Mn by 2031 at a 5.1% CAGR during the forecast period for 2024-2031.
The market for Dural Adhesive Agents in surgical settings is witnessing significant growth due to their vital role in improving surgical outcomes and patient care. These specialized adhesives are designed to seal and reinforce dural membranes during neurosurgical procedures, reducing the risk of cerebrospinal fluid leakage and postoperative complications. Key factors driving market demand include the rising incidence of neurological disorders, advancements in surgical techniques, and increasing awareness about the benefits of dural adhesive agents in minimizing surgical complications. Healthcare providers are increasingly incorporating these innovative products into their surgical protocols to enhance patient safety and recovery. With research and development efforts focusing on enhancing product efficiency, biocompatibility, and ease of application, the market for Dural Adhesive Agents in surgical applications is anticipated to grow further, offering improved surgical outcomes and patient care.
However, the COVID-19 pandemic has had a dual impact on the Dural Adhesive Agent for Surgical Market. While the increased focus on healthcare preparedness and safety measures has driven demand, disruptions in surgical procedures and supply chains have presented challenges, impacting market growth and adoption rates.
Competitive Landscape
Some of the Major Key Players in the Dural Adhesive Agent for the Surgical Market are
- Medprin
- Integra LifeSciences Corporation
- Pramand, LLC (CraniSeal)
- Stryker
- DuraStat, Inc.
- Covidien (Medtronic)
- BD
- Regenity
- Baxter
- Johnson & Johnson MedTech
Market Segmentation:
The dural adhesive agent for the surgical market is segmented by product, application, and form. On the basis of product, the market is segmented into Polyethylene glycol and other products. By application, the market is segmented into cranial surgery and spinal surgery. By form, the segmentation includes sealant glue and sealant film.
Polyethylene Glycol (PEG) Segment is a Major Contributor to the Dural Adhesive Agent for the Surgical Market
The polyethylene glycol (PEG) segment of the dural adhesive agent for the surgical market is experiencing notable growth due to its versatile applications and eco-friendly nature. PEG is widely used in pharmaceuticals, cosmetics, personal care products, and industrial processes. Its biocompatibility and biodegradability make it a preferred choice in formulations requiring safety and environmental sustainability. Increasing demand for bio-based products and stringent environmental regulations are driving the adoption of renewable PEG.
Sealant Glue and Sealant Film Segment Witness Growth at a Rapid Rate
The sealant glue and sealant film segments within the dural adhesive agent for surgical market offer specialized solutions for neurosurgical procedures. Sealant Glues provide adhesion and sealing properties for dural membrane repairs, while Sealant Films offer a protective barrier to prevent cerebrospinal fluid leakage. These innovative products play an important role in enhancing surgical outcomes, reducing complications, and improving patient recovery in neurosurgical settings.
In the Region, the North America Dural Adhesive Agent for Surgical Market Holds a Significant Revenue Share
The North America dural adhesive agent for the surgical market is estimated to see the largest share in the near future due to its advancement in healthcare infrastructure, the presence of key market players, and significant research and development (R&D) investments. Moreover, the growth in the market is also due to the growing adoption of advanced surgical procedures that need efficient tissue-sealing solutions. In addition, Asia Pacific is to be seen to grow at a rapid rate in the global dural adhesive agent for surgical market due to the prevalence of chronic diseases, rapid industrialization, government initiatives, and increasing funding in various industries.
Recent Developments:
- In November 2023, Ethicon, a Johnson & Johnson's MedTech division, launched a hemostatic sealing patch, Ethizia, for controlling bleeding in surgeries.
- In November 2023, Pramand LLC introduced the CraniSeal Dural Sealant System, which is used in cranial surgery, to the U.S. market.
- In March 2023, Animus Surgical introduced a new transparent, biodegradable, non-toxic hydrogel wound sealant.
Dural Adhesive Agent for Surgical Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 178.5 Mn |
|
Revenue Forecast In 2031 |
USD 263.2 Mn |
|
Growth Rate CAGR |
CAGR of 5.1% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Application, By Form and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Medprin, Integra LifeSciences Corporation, Pramand, LLC (CraniSeal), Stryker, DuraStat, Inc., Covidien (Medtronic), BD, Regenity, Baxter, and Johnson & Johnson MedTech. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
